Oridonin-loaded poly(ε-caprolactone)–poly(ethylene oxide)–poly(ε-caprolactone) copolymer nanoparticles: Preparation, characterization, and antitumor activity on mice with transplanted hepatoma

References

• Alakhov V, Klinski E, Lemieux P, Pietrzynski G, Kabanov A. Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Opin Biol Ther 2001; 1(4)583–602
   PubMed Web of Science ®Google Scholar
• Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S, Minami M, Ikejima T. P53-mediated cell cycle arrest and apoptosis through a caspase-3-independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin 2007; 28(7)1057–1066
   PubMed Web of Science ®Google Scholar
• Ge H, Hu Y, Jiang X, Cheng D, Yuan Y, Bi H, Yang C. Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(ε-caprolactone)–poly(ethylene oxide)–poly(ε-caprolactone) amphiphilic triblock copolymer micelles. J Pharm Sci 2002; 91(6)1463–1473
   PubMed Web of Science ®Google Scholar
• Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci U S A 1998; 95(8)4607–4612
   PubMed Web of Science ®Google Scholar
• Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL, Wu JM. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 2005; 337(1)224–231
   PubMed Web of Science ®Google Scholar
• Ikezoe T, Chen SS, Tong XJ, Heber D, Taguchi H, Koeffler HP. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int J Oncol 2003; 23(4)1187–1193
   PubMed Web of Science ®Google Scholar
• Jeong Young-II, Kang MK, Sun HS, Kang SS, Kim HW, Moon KS, Lee KJ, Kim SH, Jung S. All-trans-retinoic acid release from core-shell type nanoparticles of poly(ε-caprolactone)/poly(ethylene glycol) diblock copolymer. Int J Pharm 2004; 273(1–2)95–107
   PubMedGoogle Scholar
• Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(ε-caprolactone) as novel anticancer drug carriers. Biomaterials 2001; 22(13)1697–1704
   PubMed Web of Science ®Google Scholar
• Kim SY, Lee YM, Kang JS. Indomethacin-loaded methoxy poly(ethylene glycol)/poly(d,l-lactide) amphiphilic diblock copolymeric nanospheres: Pharmacokinetic and toxicity studies in rodents. J Biomed Mater Res A 2005; 74(4)581–590
   PubMedGoogle Scholar
• Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH, Jo HG, Park JH, Choi K, Jeong SY, Park RW, Kim IS, Kim K, Kwon IC. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release 2008; 127(1)41–49
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res 2000; 60(16)4440–4445
   PubMed Web of Science ®Google Scholar
• Li D, Wu LJ, Tashiro S, Onodera S, Ikejima T. Oridonin inhibited the tyrosine kinase activity and induced apoptosis in human epidermoid carcinoma A431 cells. Biol Pharm Bull 2007; 30(2)254–260
   PubMed Web of Science ®Google Scholar
• Ling C, Li Q, Liu X, Chen Q, Peng Y, Luo R, Huang X. Infusion of melittin-poly lactic-co-glycolic acid microspheres via hepatic artery for hepatocarcinoma in rats. World J Gastroenterol 2003; 11(7)900–903
   Google Scholar
• Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001; 41: 189–207
   PubMedGoogle Scholar
• Maeda H, Fang J, Inutsuka T, Kitamoto Y. Vascular permeability enhancement in solid tumor: Various factors, mechanisms involved and its implications. Int Immunopharmacol 2003; 3(3)319–328
   PubMed Web of Science ®Google Scholar
• Minamimura T, Sato H, Kasaoka S, Saito T, Ishizawa S, Takemori S, Tazawa K, Tsukada K. Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. Int J Oncol 2000; 16(6)1153–1158
   PubMed Web of Science ®Google Scholar
• Monsky WL, Fukumura D, Gohongi T, Ancukiewcz M, Weich HA, Torchilin VP, Yuan F, Jain RK. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res 1999; 59(16)4129–4135
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Fukushima S, Okamoto K, Suzuki M, Matsumura Y, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Development of the polymer micelle carrier system for doxorubicin. J Control Release 2001; 74(1–3)295–302
   PubMed Web of Science ®Google Scholar
• Okuda T, Kawakami S, Akimoto N, Niidome T, Yamashita F, Hashida M. PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice. J Control Release 2006; 116(3)330–336
   PubMed Web of Science ®Google Scholar
• Park EK, Kim SY, Lee SB, Lee YM. Folate-conjugated methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J Control Release 2005a; 109(1–3)158–168
   PubMed Web of Science ®Google Scholar
• Park EK, Lee SB, Lee YM. Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005b; 26(9)1053–1061
   PubMed Web of Science ®Google Scholar
• Xing J, Zhang D, Tan T. Studies on the oridonin-loaded poly(d,l-lactic acid) nanoparticles in vitro and in vivo. Int J Biol Macromol 2007; 40(2)153–158
   PubMed Web of Science ®Google Scholar
• Zhang D, Ren T. Pharmacy research review of oridonin. Chin Pharm J 2003; 38(11)817–820
   Google Scholar
• Zhang L, Hu Y, Jiang X, Yang C, Lu W, Yang YH. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release 2004; 96(1)135–148
   PubMed Web of Science ®Google Scholar
• Zhou GB, Chen SJ, Wang ZY, Chen Z. Back to the future of oridonin: Again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo. Cell Res 2007; 17(4)274–276
   PubMed Web of Science ®Google Scholar
• Zhu Y, Xie L, Chen G, Wang H, Zhang R. Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice. Pharmazie 2007; 62(6)439–444
   PubMed Web of Science ®Google Scholar